VC Deals Analysis: One Big Beat After Long Lull
After a slow summer, September delivered a much welcomed boost to venture funding levels with the first nine-figure deal in four months.
You may also be interested in...
Another slow month for VC financing deals means total deal value for 2016 to date is now lagging behind that for the same period last year.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.